Assembly Biosciences, Inc. · NASDAQ:ASMB
Dapice Joshua J. reported a 7.80% stake in Assembly Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 9, 2026
Dapice Joshua J. reported a 7.80% stake in Assembly Biosciences, Inc., 1,227,590 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 1,227,590
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 29 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Partners, L.P. | 1.50% | 239,462 |
| Farallon Capital Institutional Partners, L.P. | 1.40% | 224,245 |
| Farallon Capital Institutional Partners II, L.P. | 0.50% | 75,077 |
| Farallon Capital Institutional Partners III, L.P. | 0.30% | 48,548 |
| Four Crossings Institutional Partners V, L.P. | 0.40% | 58,135 |
| Farallon Capital Offshore Investors II, L.P. | 3.10% | 497,192 |
| Farallon Capital (AM) Investors, L.P. | 0.20% | 32,933 |
| Farallon Capital F5 Master I, L.P. | 0.30% | 51,998 |
| Farallon Partners, L.L.C. | 7.40% | 1,175,592 |
| Farallon Institutional (GP) V, L.L.C. | 0.40% | 58,135 |
| Farallon F5 (GP), L.L.C. | 0.30% | 51,998 |
| Dapice Joshua J. | 7.80% | 1,227,590 |
| Dreyfuss, Philip D. | 7.80% | 1,227,590 |
| Dunn Hannah E. | 7.80% | 1,227,590 |
| Fried, Richard B | 0% | 0 |
| Gehani, Varun N. | 7.80% | 1,227,590 |
| Giauque, Nicolas | 7.80% | 1,227,590 |
| Husen, Avner A. | 7.80% | 1,227,590 |
| Kim, David T. | 7.80% | 1,227,590 |
| Linn, Michael G. | 7.80% | 1,227,590 |
| Luo Patrick (Cheng) | 7.80% | 1,227,590 |
| Patel, Rajiv A. | 0% | 0 |
| Roberts, Jr., Thomas G. | 7.80% | 1,227,590 |
| Saito Edric C. | 7.80% | 1,227,590 |
| Seybold, William | 0% | 0 |
| Short Daniel S. | 7.80% | 1,227,590 |
| Spokes, Andrew J. M. | 7.80% | 1,227,590 |
| Warren, John R. | 7.80% | 1,227,590 |
| Wehrly, Mark C. | 7.80% | 1,227,590 |
Source
Related
- Assembly Biosciences, Inc.
- Dapice Joshua J.
- Assembly Biosciences, Inc. shareholders
- Schedule 13G · Dapice Joshua J. · Aug 15, 2025
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 4, 2026
- Form 4 · Bjorkquist Jeanette M · Jun 18, 2026
- Form 4 · Gaggar Anuj · Jun 5, 2026